Early Predictors of In-Hospital Mortality and Cardiac Dysfunction in Patients with ST-Segment Elevation Myocardial

Corina Cinezan1,2, Alexandra Manuela Buzle1,2,3, Camelia Bianca Rus1,2,3

  • 1Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.

Insights

Predictors of mortality in ST-segment elevation myocardial infarction (STEMI) include left ventricular dysfunction, anemia, and renal impairment. Early identification of these factors improves risk stratification for STEMI patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Critical Care Medicine

Background:

  • ST-segment elevation myocardial infarction (STEMI) continues to pose significant health risks despite advancements in treatment.
  • Effective risk stratification is crucial for managing STEMI patients and improving outcomes.
  • Identifying early predictors of adverse events in STEMI is essential.

Purpose of the Study:

  • To identify independent predictors of in-hospital mortality in patients with STEMI.
  • To assess the association of left ventricular ejection fraction (LVEF) and ischemic mitral regurgitation (IMR) with adverse outcomes.
  • To evaluate the role of clinical, laboratory, and echocardiographic variables in predicting mortality.

Main Methods:

  • Retrospective analysis of 512 STEMI patients undergoing revascularization within 6 hours of symptom onset.
  • Multivariable logistic regression used to identify independent predictors of in-hospital mortality.
  • Echocardiographic and laboratory data, including hemoglobin and glomerular filtration rate, were analyzed.

Main Results:

  • In-hospital mortality was observed in 9.4% of patients.
  • Reduced LVEF (<40%), moderate-to-severe IMR, lower hemoglobin, and reduced glomerular filtration rate were independent predictors of mortality.
  • The predictive model demonstrated good discrimination with an AUC of 0.88.

Conclusions:

  • Left ventricular dysfunction, IMR, anemia, and renal impairment are significant predictors of in-hospital mortality in STEMI.
  • Integrating echocardiographic and laboratory data can enhance early risk stratification for STEMI patients.
  • These findings can guide clinical decision-making and improve patient management.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...